Cargando…
Anlotinib inhibits the proliferation, migration and invasion, and induces apoptosis of breast cancer cells by downregulating TFAP2C
The vascular endothelial growth factor receptor (VEGFR) network contributes to breast cancer pathogenesis and progression. Anlotinib is a highly potent multi-target tyrosine kinase inhibitor that has been previously shown to exert antitumor effects in various types of cancer. The aim of the present...
Autores principales: | Fang, Fuxiao, Yuan, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674883/ https://www.ncbi.nlm.nih.gov/pubmed/34976158 http://dx.doi.org/10.3892/ol.2021.13164 |
Ejemplares similares
-
MicroRNA-124 suppresses the invasion and proliferation of breast cancer cells by targeting TFAP4
por: Cha, Nier, et al.
Publicado: (2021) -
Reversine inhibits proliferation, invasion and migration and induces cell apoptosis in gastric cancer cells by downregulating TTK
por: Xia, Pengfei, et al.
Publicado: (2021) -
Chromatin accessibility analysis reveals that TFAP2A promotes angiogenesis in acquired resistance to anlotinib in lung cancer cells
por: Zhang, Le-le, et al.
Publicado: (2020) -
Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma
por: Zeng, Fan-Chang, et al.
Publicado: (2016) -
Overexpression of HOXD8 inhibits the proliferation, migration and invasion of breast cancer cells by downregulating ILP2 expression
por: Wen, Xiaoyun, et al.
Publicado: (2021)